Skip to main content
PMC home page
Heart logoLink to Heart
. 2000 May;83(5):505–510. doi: 10.1136/heart.83.5.505

Survival of patients with a new diagnosis of heart failure: a population based study

M Cowie 1, D Wood 1, A Coats 1, S Thompson 1, V Suresh 1, P Poole-Wilson 1, G Sutton 1
PMCID: PMC1760808  PMID: 10768897

Abstract

OBJECTIVE—To describe the survival of a population based cohort of patients with incident (new) heart failure and the clinical features associated with mortality.
DESIGN—A population based observational study.
SETTING—Population of 151 000 served by 82 general practitioners in west London.
PATIENTS—New cases of heart failure were identified by daily surveillance of acute hospital admissions to the local district general hospital, and by general practitioner referral of all suspected new cases of heart failure to a rapid access clinic.
INTERVENTIONS—All patients with suspected heart failure underwent clinical assessment, and chest radiography, ECG, and echocardiogram were performed. A panel of three cardiologists reviewed all the data and determined whether the definition of heart failure had been met. Patients were subsequently managed by the general practitioner in consultation with the local cardiologist or admitting physician.
MAIN OUTCOME MEASURES—Death, overall and from cardiovascular causes.
RESULTS—There were 90 deaths (83 cardiovascular deaths) in the cohort of 220 patients with incident heart failure over a median follow up of 16 months. Survival was 81% at one month, 75% at three months, 70% at six months, 62% at 12 months, and 57% at 18 months. Lower systolic blood pressure, higher serum creatinine concentration, and greater extent of crackles on auscultation of the lungs were independently predictive of cardiovascular mortality (all p < 0.001).
CONCLUSIONS—In patients with new heart failure, mortality is high in the first few weeks after diagnosis. Simple clinical features can identify a group of patients at especially high risk of death.


Keywords: heart failure; prognosis; survival; epidemiology

Full Text

The Full Text of this article is available as a PDF (130.2 KB).

Figure 1  .

Figure 1  

Open in a new tab

Survival of incident cases of heart failure.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson K. D., Schwartz J. S., Chen T. M., Wong K. L., Goin J. E., Mancini D. M. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997 Jun 17;95(12):2660–2667. doi: 10.1161/01.cir.95.12.2660. [DOI] [PubMed] [Google Scholar]
  2. Campana C., Gavazzi A., Berzuini C., Larizza C., Marioni R., D'Armini A., Pederzolli N., Martinelli L., Viganò M. Predictors of prognosis in patients awaiting heart transplantation. J Heart Lung Transplant. 1993 Sep-Oct;12(5):756–765. [PubMed] [Google Scholar]
  3. Cleland J. G., Dargie H. J., Ford I. Mortality in heart failure: clinical variables of prognostic value. Br Heart J. 1987 Dec;58(6):572–582. doi: 10.1136/hrt.58.6.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cowburn P. J., Cleland J. G., Coats A. J., Komajda M. Risk stratification in chronic heart failure. Eur Heart J. 1998 May;19(5):696–710. doi: 10.1053/euhj.1997.0820. [DOI] [PubMed] [Google Scholar]
  5. Cowie M. R., Mosterd A., Wood D. A., Deckers J. W., Poole-Wilson P. A., Sutton G. C., Grobbee D. E. The epidemiology of heart failure. Eur Heart J. 1997 Feb;18(2):208–225. doi: 10.1093/oxfordjournals.eurheartj.a015223. [DOI] [PubMed] [Google Scholar]
  6. Cowie M. R., Wood D. A., Coats A. J., Thompson S. G., Poole-Wilson P. A., Suresh V., Sutton G. C. Incidence and aetiology of heart failure; a population-based study. Eur Heart J. 1999 Mar;20(6):421–428. doi: 10.1053/euhj.1998.1280. [DOI] [PubMed] [Google Scholar]
  7. Demakis J. G., Proskey A., Rahimtoola S. H., Jamil M., Sutton G. C., Rosen K. M., Gunnar R. M., Tobin J. R. The natural course of alcoholic cardiomyopathy. Ann Intern Med. 1974 Mar;80(3):293–297. doi: 10.7326/0003-4819-80-3-293. [DOI] [PubMed] [Google Scholar]
  8. Dzau V. J., Packer M., Lilly L. S., Swartz S. L., Hollenberg N. K., Williams G. H. Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. N Engl J Med. 1984 Feb 9;310(6):347–352. doi: 10.1056/NEJM198402093100603. [DOI] [PubMed] [Google Scholar]
  9. Eriksson H., Caidahl K., Larsson B., Ohlson L. O., Welin L., Wilhelmsen L., Svärdsudd K. Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. Eur Heart J. 1987 Sep;8(9):1007–1014. doi: 10.1093/oxfordjournals.eurheartj.a062365. [DOI] [PubMed] [Google Scholar]
  10. Eriksson H. Heart failure: a growing public health problem. J Intern Med. 1995 Feb;237(2):135–141. doi: 10.1111/j.1365-2796.1995.tb01153.x. [DOI] [PubMed] [Google Scholar]
  11. Fuster V., Gersh B. J., Giuliani E. R., Tajik A. J., Brandenburg R. O., Frye R. L. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981 Mar;47(3):525–531. doi: 10.1016/0002-9149(81)90534-8. [DOI] [PubMed] [Google Scholar]
  12. Hatle L., Orjavik O., Storstein O. Chronic myocardial disease. I. Clinical picture related to long-term prognosis. Acta Med Scand. 1976;199(5):399–405. [PubMed] [Google Scholar]
  13. Henry W. L., DeMaria A., Gramiak R., King D. L., Kisslo J. A., Popp R. L., Sahn D. J., Schiller N. B., Tajik A., Teichholz L. E. Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography. Circulation. 1980 Aug;62(2):212–217. doi: 10.1161/01.cir.62.2.212. [DOI] [PubMed] [Google Scholar]
  14. Johnson R. A., Palacios I. Dilated cardiomyopathies of the adult (first of two parts). N Engl J Med. 1982 Oct 21;307(17):1051–1058. doi: 10.1056/NEJM198210213071704. [DOI] [PubMed] [Google Scholar]
  15. Kelly T. L., Cremo R., Nielsen C., Shabetai R. Prediction of outcome in late-stage cardiomyopathy. Am Heart J. 1990 May;119(5):1111–1121. doi: 10.1016/s0002-8703(05)80242-x. [DOI] [PubMed] [Google Scholar]
  16. Kelly T. L., Cremo R., Nielsen C., Shabetai R. Prediction of outcome in late-stage cardiomyopathy. Am Heart J. 1990 May;119(5):1111–1121. doi: 10.1016/s0002-8703(05)80242-x. [DOI] [PubMed] [Google Scholar]
  17. Kuhn H., Becker R., Fischer J., Curtius J. M., Lösse B., Hort W., Loogen F. Untersuchungen zur Atiologie, zum Verlauf und zur Prognose der dilatativen Kardiomyopathie (DCM). Z Kardiol. 1982 Aug;71(8):497–508. [PubMed] [Google Scholar]
  18. Lee T. H., Hamilton M. A., Stevenson L. W., Moriguchi J. D., Fonarow G. C., Child J. S., Laks H., Walden J. A. Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol. 1993 Sep 15;72(9):672–676. doi: 10.1016/0002-9149(93)90883-e. [DOI] [PubMed] [Google Scholar]
  19. Lee W. H., Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation. 1986 Feb;73(2):257–267. doi: 10.1161/01.cir.73.2.257. [DOI] [PubMed] [Google Scholar]
  20. Lee W. H., Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation. 1986 Feb;73(2):257–267. doi: 10.1161/01.cir.73.2.257. [DOI] [PubMed] [Google Scholar]
  21. Parameshwar J., Keegan J., Sparrow J., Sutton G. C., Poole-Wilson P. A. Predictors of prognosis in severe chronic heart failure. Am Heart J. 1992 Feb;123(2):421–426. doi: 10.1016/0002-8703(92)90656-g. [DOI] [PubMed] [Google Scholar]
  22. Rodeheffer R. J., Jacobsen S. J., Gersh B. J., Kottke T. E., McCann H. A., Bailey K. R., Ballard D. J. The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc. 1993 Dec;68(12):1143–1150. doi: 10.1016/s0025-6196(12)60063-9. [DOI] [PubMed] [Google Scholar]
  23. Sahn D. J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978 Dec;58(6):1072–1083. doi: 10.1161/01.cir.58.6.1072. [DOI] [PubMed] [Google Scholar]
  24. Scrutinio D., Lagioia R., Ricci A., Clemente M., Boni L., Rizzon P. Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring. Eur Heart J. 1994 Aug;15(8):1089–1095. doi: 10.1093/oxfordjournals.eurheartj.a060633. [DOI] [PubMed] [Google Scholar]
  25. Senni M., Tribouilloy C. M., Rodeheffer R. J., Jacobsen S. J., Evans J. M., Bailey K. R., Redfield M. M. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998 Nov 24;98(21):2282–2289. doi: 10.1161/01.cir.98.21.2282. [DOI] [PubMed] [Google Scholar]
  26. Shumway N. E. Cardiac transplantation. J Am Coll Cardiol. 1993 Jul;22(1):6–7. doi: 10.1016/0735-1097(93)90809-f. [DOI] [PubMed] [Google Scholar]
  27. Stevenson L. W., Perloff J. K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989 Feb 10;261(6):884–888. [PubMed] [Google Scholar]
  28. Szlachcic J., Massie B. M., Kramer B. L., Topic N., Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol. 1985 Apr 1;55(8):1037–1042. doi: 10.1016/0002-9149(85)90742-8. [DOI] [PubMed] [Google Scholar]
  29. Unverferth D. V., Magorien R. D., Moeschberger M. L., Baker P. B., Fetters J. K., Leier C. V. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol. 1984 Jul 1;54(1):147–152. doi: 10.1016/0002-9149(84)90320-5. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES